Skip to main content

Table 4 Cost, quality-adjusted life-years (QALY), and incremental cost-effectiveness ratio (ICER) values

From: Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients

  Cost ($) QALY ICER ($/QALY, relative to the adjacent cost-effective technique)
SOC 15,352 9.214
STD-VMAT 19,131 9.33 32,617
TOMO 20,267 9.314 Dominated by STD-VMAT
IMRT 20,543 9.404 19,081
MA-VMAT 20,617 9.365 Dominated by IMRT
NC-VMAT 20,633 9.402 Dominated by IMRT
MIXED 22,985 9.385 Dominated by IMRT
IMPT 38,145 9.52 151,741
\